- The report contains detailed information about BELLUS Health Inc. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
- Another part of the report is a SWOT-analysis carried out for BELLUS Health Inc.. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
- The BELLUS Health Inc. financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
- In the part that describes BELLUS Health Inc. competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
- Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of BELLUS Health Inc. business.
About BELLUS Health Inc.
BELLUS Health Inc. engages in the research, development and commercialization of products for health solutions. The companys operations are conducted principally in Canada and Europe.
The companys wholly owned subsidiary, OVOS Natural Health Inc., which launched its primary product VIVIMIND (also known as tramiprosate and homotaurine) in 2008, is engaged in the research, development and commercialization of branded natural health products. VIVIMIND is a natural health brand designed to protect memory function and is based on homotaurine, a naturally occurring ingredient found in certain seaweed.
Eprodisate (KIACTA)
Eprodisate (KIACTA) is the companys oral investigational product candidate for the treatment of AA amyloidosis, a potentially fatal disease which is often associated with kidney dysfunction. During 2008, the company announced its decision to continue the drug development program for eprodisate (KIACTA) and that it planned to initiate a second Phase III clinical trial for eprodisate (KIACTA) in cooperation with the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMEA).
NC-503 (eprodisate)
The company is developing NC-503 (eprodisate) for the treatment of Type II diabetes and certain features of metabolic syndrome. During 2008, a Phase II clinical trial in diabetic patients was initiated in Canada and patient recruitment and randomization commenced.
Prodrug of Tramiprosate
The companys product prodrug of tramiprosate is used for Alzheimers disease indication and is in preclinical development.
Acquisitions
In 2008, the company acquired 100% of Innodia Inc. (Innodia), a private, development stage company engaged in developing compounds for the treatment of diabetes, obesity and related metabolic conditions and diseases.
History
The company was founded in 2003. It was formerly known as Neurochem Inc. and changed its name to BELLUS Health Inc. in 2008.
RESEARCH METHODOLOGY
DISCLAIMER
1. BELLUS HEALTH INC. COMPANY PROFILE
1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History
2. BELLUS HEALTH INC. BUSINESS OVERVIEW
2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units
3. BELLUS HEALTH INC. SWOT ANALYSIS
3.1. Overview
3.2. Strengths
3.3. Weaknesses
3.4. Opportunities
3.5. Threats
4. BELLUS HEALTH INC. FINANCIAL ANALYSIS
4.1. Financial Statements
4.1.1. Income Statement
4.1.2. Balance Sheet
4.1.3. Cash Flow
4.2. Financial Ratios
4.2.1. Profitability
4.2.2. Margin Analysis
4.2.3. Asset Turnover
4.2.4. Credit Ratios
4.2.5. Long-Term Solvency
4.2.6. Growth Over Prior Year
4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot
5. BELLUS HEALTH INC. COMPETITORS AND INDUSTRY ANALYSIS
5.1. BELLUS Health Inc. Direct Competitors
5.2. Comparison of BELLUS Health Inc. and Direct Competitors Financial Ratios
5.3. Comparison of BELLUS Health Inc. and Direct Competitors Stock Charts
5.4. BELLUS Health Inc. Industry Analysis
5.4.1. Pharmaceuticals and Biotechnology Industry Snapshot
5.4.2. BELLUS Health Inc. Industry Position Analysis
6. BELLUS HEALTH INC. NEWS & EVENTS
6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events
7. BELLUS HEALTH INC. EXPERTS REVIEW*
7.1. Experts Opinion
7.2. Experts Estimates
APPENDIX 1: RATIO DEFINITIONS
LIST OF TABLES
BELLUS Health Inc. Key Facts
Profitability
Management Effectiveness
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
BELLUS Health Inc. Key Executives
Key Executives Biographies*
Key Executives Compensations*
BELLUS Health Inc. Major Shareholders
BELLUS Health Inc. History
BELLUS Health Inc. Products
Revenues by Product
Revenues by Region
BELLUS Health Inc. Offices and Representations
BELLUS Health Inc. SWOT Analysis
Income Statement 2009-2012 Including 4-years Trends
Income Statement Latest 4 Quarters Including Trends
Balance Sheet 2009-2012 Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Cash Flow 2009-2012 Including Trends
Cash Flow Latest 4 Quarters Including Trends
BELLUS Health Inc. Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Credit Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
BELLUS Health Inc. Capital Market Snapshot
BELLUS Health Inc. Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Pharmaceuticals and Biotechnology Industry Statistics
BELLUS Health Inc. Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
BELLUS Health Inc. Consensus Recommendations*
Analyst Recommendation Summary*
Price Target Summary*
Experts Recommendation Trends*
Revenue Estimates Analysis*
Earnings Estimates Analysis*
Historical Surprises*
Revenue Estimates Trend*
Earnings Estimates Trend*
Revenue Revisions*
Earnings Revisions*
LIST OF FIGURES
BELLUS Health Inc. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
BELLUS Health Inc. 1-year Stock Charts
BELLUS Health Inc. 5-year Stock Charts
BELLUS Health Inc. vs. Main Indexes 1-year Stock Chart
BELLUS Health Inc. vs. Direct Competitors 1-year Stock Charts
BELLUS Health Inc. Article Density Chart
* – Data availability depends on company’s security policy.
The complete financial data is available for public traded companies.
The above Company Fundamental Report is a half-ready report.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get up-to-date version for the same price.
